Veterinary Medicines

BAYTRIL 2,5% W/V ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ

Authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
BAYTRIL 2,5% W/V ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
  • Enrofloxacin
Target species:
  • Pig (piglet)
  • Reptile
  • Ornamental bird
  • Dog
  • Cat
  • Rabbit
  • Rodents
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Enrofloxacin
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (piglet)
      • Meat and offal
        13
        day
    • Reptile
      • Not applicable
        no withdrawal period
    • Ornamental bird
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
    • Rabbit
      • Meat and offal
        6
        day
    • Rodents
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 1241/10-01-2011/K-0051709
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."